Aristea S. Galanopoulou MD, PhD, FANA, FAES

Dr. Aristea S. Galanopoulou is a Professor of neurology and neuroscience at the Albert Einstein College of Medicine, Bronx, NY. She received her MD from the Medical School of Athens, Greece; PhD from McGill University, Canada; and her neurology and clinical neurophysiology training from the Albert Einstein College of Medicine.

Her research focuses on mechanisms involved in the pathogenesis and identifying new age-, sex, and syndrome-specific therapies for seizures and epileptic syndromes that appear early in life, by using age- and syndrome-specific animal models. These studies have identified several promising new therapies for infantile spasms, including treatments with disease-modifying potential, which are currently under development. Dr. Galanopoulou is also leading preclinical National Institute of Neurological Disorders and Stroke and the Department of Defense-funded multicenter studies for biomarkers and treatments that prevent posttraumatic epilepsy.

Dr. Galanopoulou has been co-chair of the AES/International League Against Epilepsy (ILAE) Joint Translational Research Task Force and chair of ILAE’s Neurobiology Commission. She is the editor-in-chief of Epilepsia Open and associate editor of Neurobiology of Disease. She received the Ambassador for Epilepsy Award from ILAE in 2015, the Saul R. Korey Award in Translational Science and Medicine from the Albert Einstein College of Medicine in 2017, and was the 2023 Isabelle Rapin Lecturer for Montefiore Health System, the University Hospital for Albert Einstein College of Medicine, New York.